Ironwood Pharmaceuticals | IRWD - Lngresos Netos

Precio De Mercado
4.18
Cambio Diario
-0.04 -0.95%
Mensual
14.52%
Anual
469.64%
Q2 Expectativa
4.13




Lngresos Netos Cambio Fecha
Acadia Pharmaceuticals USD 3.64M 269.93M 2026-03
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Almirall EUR 19.58M 7M 2025-12
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Amarin USD -1.22M 6.51M 2025-12
Ardelyx USD -407K 562K 2025-12
Astellas Pharma JPY 43.52B 56.86B 2026-03
AstraZeneca USD 3.08B 754M 2026-03
Charles River Laboratories USD -14.84M 261.71M 2026-03
Coherus Biosciences USD -37.64M 2.11M 2025-12
Emergent BioSolutions USD -261.3M 78.3M 2023-06
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Halozyme Therapeutics USD -141.59M 316.82M 2025-12
Incyte USD 303.33M 4.05M 2026-03
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
Karyopharm Therapeutics USD -102.2M 71.42M 2025-12
Lexicon Pharmaceuticals USD -15.53M 2.76M 2025-12
MacroGenics USD -14.16M 30.98M 2025-12
Moderna USD -1.34B 517M 2026-03
Myriad Genetics USD -7.9M 19.5M 2025-12
Pacira USD 2.92M 1.28M 2026-03
PTC Therapeutics USD -2.81M 132.16M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Takeda JPY 103.64B 115.44B 2025-12
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12